Maciel Mara Graziele, Fruitg Mayra, Lawall Rebeca Pissolati, Maciel Alexandre Toledo
Department of Geriatric and Palliative Care, Hospital São Camilo Ipiranga, São Paulo, Brazil.
Imed Research Group, São Paulo, Brazil.
Indian J Palliat Care. 2021 Oct-Dec;27(4):530-537. doi: 10.25259/IJPC_112_21. Epub 2021 Nov 9.
Antibiotic use in palliative care patients is a frequent dilemma. The benefits of their use in terms of quality of end-of-life care or survival improvement are not clear and the potential harm and futility of this practice not well established. Our aim was to characterise the prevalence of antibiotic use, documented infection and multidrug-resistant organisms (MDROs) colonisation among palliative care patients admitted to a private hospital in Brazil.
Retrospective analysis of all palliative care patients admitted to our hospital during 1 year, including demographic characteristics, diagnosis of infectious disease at admission, antibiotic use during hospital stay, infectious agents isolated in cultures, documented MDRO colonisation and hospital mortality.
A total of 114 patients were included in the analysis. Forty-five (39%) were male and the median age was 83 years. About 78% of the patients had an infectious diagnosis at hospital admission and 80% of the patients not admitted with an infectious diagnosis used antibiotics during their stay, out of which a great proportion of large spectrum antibiotics. Previous MDRO colonisation and hospital mortality were similar between patients admitted with or without an infectious diagnosis.
Infection is the leading cause of hospital admission in palliative care patients. However, antibiotics prescription is also very prevalent during hospital stay of patients not admitted with an infectious condition. Mortality is very high regardless of the initial reason for hospital admission. Therefore, the impact of multiple large spectrum antibiotics prescription and consequent significant cost burden should be urgently confronted with the real benefit to these patients.
姑息治疗患者使用抗生素是一个常见的难题。其在临终关怀质量或改善生存方面的益处尚不明确,且这种做法的潜在危害和无效性也未得到充分证实。我们的目的是描述巴西一家私立医院收治的姑息治疗患者中抗生素使用、记录在案的感染以及多重耐药菌(MDROs)定植的发生率。
对我院1年内收治的所有姑息治疗患者进行回顾性分析,包括人口统计学特征、入院时的传染病诊断、住院期间的抗生素使用、培养分离出的感染病原体、记录在案的MDRO定植情况以及医院死亡率。
共有114例患者纳入分析。45例(39%)为男性,中位年龄为83岁。约78%的患者入院时患有感染性疾病,80%入院时无感染性疾病诊断的患者在住院期间使用了抗生素,其中很大一部分使用的是广谱抗生素。有或无感染性疾病诊断的患者,既往MDRO定植情况和医院死亡率相似。
感染是姑息治疗患者入院的主要原因。然而,在无感染性疾病入院的患者住院期间,抗生素处方也非常普遍。无论入院的初始原因如何,死亡率都很高。因此,应紧急权衡多种广谱抗生素处方的影响以及随之而来的巨大成本负担与这些患者实际获得的益处。